Redwing Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Redwing Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $349.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Redwing Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $349.5K Trade | TransData Nexus

Redwing Pharma Private Limited

Indian Pharmaceutical Exporter · Antimalarial & Antiparasitic Specialist · $349.5K Total Trade · DGFT Verified

Redwing Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $349.5K across 2 products in 2 therapeutic categories. Based on 9 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Quinine ($300.0K), Antitoxin ($49.5K), .

Redwing Pharma Private Limited — Export Portfolio & Destination Treemap

Redwing Pharma Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Redwing Pharma Private Limited? — Company Overview & Market Position

Redwing Pharma Private Limited, incorporated on July 22, 2008, is a private, non-government company registered under the Corporate Identification Number (CIN) U24239MH2008PTC184934. The company is headquartered at 110, Krishna Bhavan Annex, Bhaktakavi Shivji Devshi Marg, Deonar, Mumbai, Maharashtra 400088, India. It operates in the manufacturing sector, specifically in the production of pharmaceutical formulations. The authorized and paid-up capital of the company is ₹10 lakhs, indicating a modest financial base. As of the latest available data, the company employs between 1 to 10 individuals, reflecting its small scale of operations. The company's mission is to make affordable and quality medicines available worldwide, addressing the healthcare needs of underserved populations.

What Does Redwing Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Quinine$300.0K 2Antitoxin$49.5K

Product Portfolio — Top 2 by Export Value

Redwing Pharma Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Quinine	Antimalarial & Antiparasitic	$300.0K	6	1.6%	8
2	Antitoxin	Other	$49.5K	3	0.4%	11

Redwing Pharma Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $349.5K. The top category is Antimalarial & Antiparasitic (85.8% of portfolio), followed by Other (14.2%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Redwing Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Redwing Pharma Private Limited's manufacturing facility is located in Mumbai, Maharashtra. The plant specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. While specific details regarding production capacities and specialized manufacturing capabilities are not publicly disclosed, the company's focus on finished dosage forms suggests adherence to industry standards for quality and safety.

3Key Leadership

The leadership team of Redwing Pharma Private Limited comprises:

Gaurav Prakash Jain: Additional Director, appointed on May 10, 2011.

Ruchika Jain: Additional Director, appointed on July 22, 2008.

The company's founder, Mr. P.C. Jain, is a veteran in the Indian pharmaceutical industry and has been instrumental in establishing Redwing Pharma as a marketing wing for a group of companies, aiming to expand their global presence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Redwing Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Redwing Pharma Private Limited's export activities, as per TransData Nexus proprietary trade data, include shipments totaling $350,000 USD across 9 transactions, with products spanning two therapeutic categories. The primary markets for these exports are not specified in the available data. The company's focus on finished pharmaceutical formulations suggests compliance with international regulatory standards, which is essential for market access in regions such as the United States, European Union, United Kingdom, Australia, and Japan. However, specific regulatory filings, approvals, and market access statuses in these regions are not detailed in the available information.

2Emerging Markets

Redwing Pharma Private Limited's export data indicates a concentration in the Antimalarial & Antiparasitic therapeutic category, accounting for 85.8% of their exports. This focus aligns with the healthcare needs in emerging markets, particularly in Africa, Latin America, and Southeast Asia, where such diseases are prevalent. While the company's mission includes making affordable and quality medicines available worldwide, specific details regarding WHO prequalification or other certifications enabling access to these markets are not provided in the available information.

3Geographic Strategy

Redwing Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Redwing Pharma Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not available in the provided data. Given the company's focus on finished pharmaceutical formulations, obtaining FDA approvals would be crucial for market access in the United States. The absence of publicly available information suggests that the company may not currently have FDA-approved products or facilities.

2WHO & EU GMP

Details regarding Redwing Pharma Private Limited's WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not available in the provided information. These certifications are essential for market access in various international markets and for ensuring compliance with global quality standards.

3CDSCO & Indian Regulatory

The company's manufacturing facility is registered with the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority for pharmaceuticals in India. Specific details regarding CDSCO manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not provided in the available data. Compliance with CDSCO regulations is mandatory for the production and export of pharmaceutical products from India.

Redwing Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the Antimalarial & Antiparasitic therapeutic category, Redwing Pharma Private Limited faces competition from both domestic and international pharmaceutical companies. The company's export data indicates a market share of 1.6% for Quinine, ranking 8th in this category, and a market share of 0.4% for Antitoxin, ranking 11th. This suggests a relatively modest presence in the global market, with opportunities for growth through strategic initiatives such as product diversification, geographic expansion, and strengthening regulatory compliance.

2Key Differentiators

Redwing Pharma Private Limited's key differentiators include its focus on finished pharmaceutical formulations, which allows for greater control over product quality and compliance with international standards. The company's mission to make affordable and quality medicines available worldwide aligns with global health objectives, potentially enhancing its appeal in emerging markets. However, the lack of diversification in its product portfolio and limited publicly available information regarding regulatory approvals may pose challenges in differentiating the company in a competitive market.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Redwing Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Redwing Pharma Private Limited's export data indicates a total export value of $350,000 USD across 9 shipments, with a portfolio concentration of 100% in the top five products. This suggests a focused approach to product offerings and a consistent export volume. However, the lack of diversification in the product portfolio and limited information regarding regulatory approvals may impact the company's reliability and consistency in meeting international standards.

2Certifications to Verify

Importers should verify the following certifications to ensure compliance with international standards:

FDA Approval: To confirm that the company's products meet the safety and efficacy standards required for the U.S. market. Verification can be done through the FDA's official website or by contacting the company directly.

WHO-GMP Certification: To ensure that the manufacturing processes adhere to the World Health Organization's Good Manufacturing Practice guidelines. Verification can be done through the WHO's official website or by contacting the company directly.

Frequently Asked Questions — Redwing Pharma Private Limited

How many pharmaceutical products does Redwing Pharma Private Limited export from India?

Redwing Pharma Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Quinine ($300.0K), Antitoxin ($49.5K). Total export value is $349.5K.

What is Redwing Pharma Private Limited's total pharmaceutical export value?

Redwing Pharma Private Limited's total pharmaceutical export value is $349.5K, based on 9 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Redwing Pharma Private Limited cover?

Redwing Pharma Private Limited exports across 2 therapeutic categories. The largest are Antimalarial & Antiparasitic (85.8%, 1 products), Other (14.2%, 1 products).

Get Full Redwing Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.